The Patent Finder

Sanguibiotech GmbH

Also on record
Records under this name other than patents Sanguibiotech GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Sanguibiotech GmbH

PatentTitleStatus Expires Confidence
US 7,005,414Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof
Term ended
Ended no later than Jun 12, 2021 · From the USPTO record
Term endedEnded no later than Jun 12, 2021From the USPTO record
US 6,956,025Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof
Lapsed on the fee record
Ended Oct 18, 2017 · From the USPTO record
Lapsed on the fee recordEnded Oct 18, 2017From the USPTO record
US 7,598,220Use of hyperpolymeric hemoglobin for the treatment of pulmonary edema
Lapsed on the fee record
Ended Oct 6, 2017 · From the USPTO record
Lapsed on the fee recordEnded Oct 6, 2017From the USPTO record
US 5,985,332Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof
Term ended
Term ended no later than Nov 16, 2019 · Low confidence
Term endedTerm ended no later than Nov 16, 2019Low confidence
US 5,994,509Method for obtaining uniform fractions of hyperpolymeric hemoglobins
Term ended
Term ended no later than Nov 30, 2019 · Low confidence
Term endedTerm ended no later than Nov 30, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited